Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Canevari

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|October 23, 1997
Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cellsV Ramakrishna, D R Negri, V Brusic, et al.
FEBS Letters|August 2, 2001
Exon 3 of the alpha folate receptor gene contains a 5' splice site which confers enhanced ovarian carcinoma specific expressionE Galmozzi, A Tomassetti, S Sforzini, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Approaches to implement bispecific antibody treatment of ovarian carcinomaS Canevari, D Mezzanzanica, A Mazzoni, et al.
Oncogene|December 14, 2011
Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancerC Alberti, P Pinciroli, B Valeri, et al.
Cancer Gene Therapy|January 23, 1999
Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cellsD Mezzanzanica, S Canevari, A Mazzoni, et al.
British Journal of Haematology|September 12, 1998
Targeting of saporin to Hodgkin's lymphoma cells by anti-CD30 and anti-CD25 bispecific antibodiesS Sforzini, D de Totero, A Gaggero, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19L T Mantovani, S Miotti, S Ménard, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal modelM Ripamonti, S Canevari, S Ménard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prognostic significance of the CaMBr1 antigen on breast carcinoma: relevance of the type of recognised glycoconjugateF Perrone, S Ménard, S Canevari, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Evaluation of the suitability of a monoclonal antibody raised against human ovarian carcinoma for therapeutic approachesM I Colnaghi, G L Buraggi, S Canevari, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|October 23, 1997
Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cellsV Ramakrishna, D R Negri, V Brusic, et al.
FEBS Letters|August 2, 2001
Exon 3 of the alpha folate receptor gene contains a 5' splice site which confers enhanced ovarian carcinoma specific expressionE Galmozzi, A Tomassetti, S Sforzini, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Approaches to implement bispecific antibody treatment of ovarian carcinomaS Canevari, D Mezzanzanica, A Mazzoni, et al.
Oncogene|December 14, 2011
Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancerC Alberti, P Pinciroli, B Valeri, et al.
Cancer Gene Therapy|January 23, 1999
Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cellsD Mezzanzanica, S Canevari, A Mazzoni, et al.
British Journal of Haematology|September 12, 1998
Targeting of saporin to Hodgkin's lymphoma cells by anti-CD30 and anti-CD25 bispecific antibodiesS Sforzini, D de Totero, A Gaggero, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19L T Mantovani, S Miotti, S Ménard, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal modelM Ripamonti, S Canevari, S Ménard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prognostic significance of the CaMBr1 antigen on breast carcinoma: relevance of the type of recognised glycoconjugateF Perrone, S Ménard, S Canevari, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Evaluation of the suitability of a monoclonal antibody raised against human ovarian carcinoma for therapeutic approachesM I Colnaghi, G L Buraggi, S Canevari, et al.
Pageof 14